Logo image of MCFE

MCAFEE CORP - CLASS A (MCFE) Stock Fundamental Analysis

NASDAQ:MCFE - Nasdaq - Common Stock

25.99  -0.01 (-0.04%)

After market: 25.99 0 (0%)

Fundamental Rating

1

Overall MCFE gets a fundamental rating of 1 out of 10. We evaluated MCFE against 284 industry peers in the Software industry. MCFE has a bad profitability rating. Also its financial health evaluation is rather negative. MCFE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

MCFE had positive earnings in the past year.
MCFE Yearly Net Income VS EBIT VS OCF VS FCFMCFE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 0 500M -500M

1.2 Ratios

Industry RankSector Rank
ROA 25.69%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MCFE Yearly ROA, ROE, ROICMCFE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 0 20 40 60 80 100

1.3 Margins

Industry RankSector Rank
OM 30.99%
PM (TTM) 37.21%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MCFE Yearly Profit, Operating, Gross MarginsMCFE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 0 20 -20 40 60

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, MCFE has more shares outstanding
MCFE has a worse debt/assets ratio than last year.
MCFE Yearly Shares OutstandingMCFE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 100M 200M 300M 400M
MCFE Yearly Total Debt VS Total AssetsMCFE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.55, we must say that MCFE is in the distress zone and has some risk of bankruptcy.
MCFE has a Debt/Equity ratio of -0.35. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.35
Debt/FCF N/A
Altman-Z 1.55
ROIC/WACCN/A
WACCN/A
MCFE Yearly LT Debt VS Equity VS FCFMCFE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 0 2B -2B 4B -4B -6B -8B

2.3 Liquidity

MCFE has a Current Ratio of 0.82. This is a bad value and indicates that MCFE is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.82 indicates that MCFE may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
MCFE Yearly Current Assets VS Current LiabilitesMCFE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 707.81% over the past year.
The Revenue has decreased by -8.27% in the past year.
The Revenue has been decreasing by -1.93% on average over the past years.
EPS 1Y (TTM)707.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.95%
Revenue 1Y (TTM)-8.27%
Revenue growth 3Y-7.28%
Revenue growth 5Y-1.93%
Sales Q2Q%-33.08%

3.2 Future

MCFE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.47% yearly.
The Revenue is expected to grow by 10.85% on average over the next years. This is quite good.
EPS Next Y-27.57%
EPS Next 2Y-4.99%
EPS Next 3Y2.17%
EPS Next 5Y6.47%
Revenue Next Year12.05%
Revenue Next 2Y11.4%
Revenue Next 3Y10.67%
Revenue Next 5Y10.85%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MCFE Yearly Revenue VS EstimatesMCFE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
MCFE Yearly EPS VS EstimatesMCFE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.20, MCFE is valued correctly.
Compared to an average S&P500 Price/Earnings ratio of 26.65, MCFE is valued a bit cheaper.
A Price/Forward Earnings ratio of 20.98 indicates a rather expensive valuation of MCFE.
MCFE is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.27, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.2
Fwd PE 20.98
MCFE Price Earnings VS Forward Price EarningsMCFE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14
MCFE Per share dataMCFE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.99%
EPS Next 3Y2.17%

0

5. Dividend

5.1 Amount

MCFE has a Yearly Dividend Yield of 1.77%.
MCFE's Dividend Yield is slightly below the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.77%

5.2 History

MCFE is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A
MCFE Yearly Dividends per shareMCFE Yearly Dividends per shareYearly Dividends per share 2020 2021 2 4 6 8

5.3 Sustainability

MCFE pays out 94.77% of its income as dividend. This is not a sustainable payout ratio.
DP94.77%
EPS Next 2Y-4.99%
EPS Next 3Y2.17%
MCFE Yearly Income VS Free CF VS DividendMCFE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 0 500M -500M 1B 1.5B
MCFE Dividend Payout.MCFE Dividend Payout, showing the Payout Ratio.MCFE Dividend Payout.PayoutRetained Earnings

MCAFEE CORP - CLASS A

NASDAQ:MCFE (2/28/2022, 8:25:48 PM)

After market: 25.99 0 (0%)

25.99

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)05-02 2022-05-02
Inst Owners0.01%
Inst Owner Change0%
Ins Owners0.14%
Ins Owner Change0%
Market Cap11.46B
Analysts50.91
Price Target26.52 (2.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.77%
Yearly Dividend0.35
Dividend Growth(5Y)N/A
DP94.77%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.2
Fwd PE 20.98
P/S 4.85
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 14
EPS(TTM)1.71
EY6.58%
EPS(NY)1.24
Fwd EY4.77%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.36
BVpS-18.68
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 25.69%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 30.99%
PM (TTM) 37.21%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity -0.35
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 1.55
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)707.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.95%
EPS Next Y-27.57%
EPS Next 2Y-4.99%
EPS Next 3Y2.17%
EPS Next 5Y6.47%
Revenue 1Y (TTM)-8.27%
Revenue growth 3Y-7.28%
Revenue growth 5Y-1.93%
Sales Q2Q%-33.08%
Revenue Next Year12.05%
Revenue Next 2Y11.4%
Revenue Next 3Y10.67%
Revenue Next 5Y10.85%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A